GL1X · GenesisL1 explorer

Research workbench

Plasminogen activator (tsv-pa) from snake venom

Analyse Plasminogen activator (tsv-pa) from snake venom in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1BQY
Type
protein
Length
468 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Plasminogen activator
Ligands
0GJ
Pockets
2 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPlasminogen activatorprotein23410% helix, 33% strand—

Ligands and binding sites

  • 0GJ · L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11230.450.77220GJ
21040.420.77200GJ

Modifications

Observed in the structure: 12 disulfide, 4 covalent (disulfide, covalent ligand).

Compared structures

  • 1BQY · Plasminogen activator (TSV-PA) from snake venom · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.